Eculizumab biosimilar 更新时间：2023-04-03 13:21:43 常用名 托西珠单抗 CAS号 219685-50-4 价钱 $需询单/100mg $需询单/500mg $需询单/1g $需询单/2g 纯度 98.0% 备货期 需询单 库存 现货 产物详情（用途，包装等） Eculizumab biosimilar is a recombinant humanized monoclonal IgG2/4κ antibody produced by Chinese hamster ovary cell culture and purified by standard bioprocess technology. Eculizumab biosimilar contains human constant regions from human IgG2 sequences and human IgG4 sequences and murine complementarity-determining regions grafted onto the human framework light- and heavy-chain variable regions. Eculizumab biosimilaris composed of two 448 amino acid heavy chains and two 214 amino acid light chains and has a molecular weight of approximately 148 kDa. Eculizumab biosimilar is supplied at a concentration of 10 mg/mL as a sterile, preservative-free, clear, colorless solution of pH 7.0, which contains 0.46 mg/mL sodium phosphate monobasic, 1.78 mg/mL sodium phosphate dibasic, 8.77 mg/mL sodium chloride, 0.22 mg/mL polysorbate 80 (vegetable origin). Statement: this product is used for R&D only, not for clinical usage. 供应商信息 上海拓普韦尔生物医药科技有限公司 认证状态： 未认证供应商 电话： +86-02158180488 地址： Room 315, Building 3, No. 1666, Xinyang Highway, Lin-gang Special Area of China (Shanghai) Pilot Free Trade Zone 区域： China 联系人： Bruce 联系人电话： +86-21-58180488 邮件： sales@topwellpharma.com 网址： www.topwellpharma.com 主要市场： Europe and America